This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Treatment

Authoring team

Co-trimoxazole appears to be the treatment of choice in both immunocompetent and immunocompromised hosts.

  • in immunocompetent adults:
    • trimethoprim-sulfamethoxazole (TMP-SMX) (TMP 160 mg plus SMX 800 mg) orally, twice a day, for 7 – 10 days

Reference:

  1. Centers for Disease Control and Prevention. Clinical care of cyclosporiasis. Published February 27, 2024. Accessed August 5, 2026. https://www.cdc.gov/cyclosporiasis/hcp/clinical-care/index.html

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.